Electrospun Rapamycin-Eluting Polyurethane Fibers for Vascular Grafts

Pharmaceutical Research

Volumn 30, Issue 7, 2013, Pages 1735-1748

  Han, Jingjia ^a   Farah, Shady ^b   Domb, Abraham J ^b   Lelkes, Peter I ^a  

^a DREXEL UNIVERSITY   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

drug release; electrospinning; rapamycin; restenosis; smooth muscle cell

Indexed keywords

POLYURETHAN; RAPAMYCIN;

ANIMAL CELL; AORTA MEDIA; ARTICLE; BLOOD VESSEL GRAFT; CELL PROLIFERATION; CONTROLLED STUDY; COW; DRUG EFFECT; DRUG ELUTING VASCULAR GRAFT; DRUG RELEASE; ELECTROSPINNING; ENCAPSULATION; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TENSILE STRENGTH; YOUNG MODULUS;

ANIMALS; AORTA; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; DRUG CARRIERS; ELASTIC MODULUS; IMMUNOSUPPRESSIVE AGENTS; MUSCLE CELLS; POLYURETHANES; SIROLIMUS;

EID: 84878832968     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1016-5     Document Type: Article

References (40)

1. Liu MW, Roubin GS, King III SB. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation. 1989;79:1374-87. (Pubitemid 19155772)
2. Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet. 2003;361:247-9. (Pubitemid 36126229)
3. Allaire E, Clowes AW. Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. Ann Thorac Surg. 1997;63:582-91. (Pubitemid 27084610)
4. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998-1008. (Pubitemid 46376800)
5. Kim YH, Park SW, Lee SW, Park DW, Yun SC, Lee CW, et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation. 2006;114:2148-53. (Pubitemid 44747895)
6. Adelman SJ. Sirolimus and its analogs and its effects on vascular diseases. Curr Pharm Des. 2010;16:4002-11.
7. Wang X, Venkatraman SS, Boey FY, Loo JS, Tan LP. Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials. 2006;27:5588-95. (Pubitemid 44176151)
8. Luong-Van E, Grondahl L, Chua KN, Leong KW, Nurcombe V, Cool SM. Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials. 2006;27:2042-50. (Pubitemid 41759498)
9. Khan W, Farah S, Domb AJ. Drug eluting stents: developments and current status. J Control Release. 2012;161:703-12.
10. Biondi M, Ungaro F, Quaglia F, Netti PA. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev. 2008;60:229-42. (Pubitemid 350236401)
11. Kowalczyk T, Nowicka A, Elbaum D, Kowalewski TA. Electrospinning of bovine serum albumin. Optimization and the use for production of biosensors. Biomacromolecules. 2008;9:2087-90.
12. Montero RB, Vial X, Nguyen DT, Farhand S, Reardon M, Pham SM, et al. bFGF-containing electrospun gelatin scaffolds with controlled nano-architectural features for directed angiogenesis. Acta Biomater. 2012;8:1778-91.
13. Ekaputra AK, Prestwich GD, Cool SM, Hutmacher DW. The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (epsilon-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Biomaterials. 2011;32:8108-17.
14. Hyung II RM, Kim JS, Konno T, Takai M, Ishihara K. Preparation of electrospun poly(L-lactide-co-caprolactone-co-glycolide)/phospholipid polymer/rapamycin blended fibers for vascular application. Curr Appl Phys. 2009;9:249-51.
15. Okuda T, Tominaga K, Kidoaki S. Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes. J Control Release. 2010;143:258-64.
16. Xie J, Wang CH. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm Res. 2006;23:1817-26. (Pubitemid 44200545)
17. Cui W, Li X, Zhu X, Yu G, Zhou S, Weng J. Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation. Biomacromolecules. 2006;7:1623-9. (Pubitemid 43811221)
18. Li M, Guo Y, Wei Y, MacDiarmid AG, Lelkes PI. Electrospinning polyaniline-contained gelatin nanofibers for tissue engineering applications. Biomaterials. 2006;27:2705-15. (Pubitemid 43122074)
19. Li M, Mondrinos MJ, Chen X, Gandhi MR, Ko FK, Lelkes PI. Co-electrospun poly(lactide-co-glycolide), gelatin, and elastin blends for tissue engineering scaffolds. J Biomed Mater Res A. 2006;79:963-73. (Pubitemid 44915916)
20. Uttayarat P, Perets A, Li M, Pimton P, Stachelek SJ, Alferiev I, et al. Micropatterning of three-dimensional electrospun polyurethane vascular grafts. Acta Biomater. 2010;6:4229-37.
21. Crapo PM, Wang Y. Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrate. Biomaterials. 2010;31:1626-35.
22. Han J, Lazarovici P, Pomerantz C, Chen X, Wei Y, Lelkes PI. Co-electrospun blends of PLGA, gelatin, and elastin as potential nonthrombogenic scaffolds for vascular tissue engineering. Biomacromolecules. 2011;12:399-408.
23. Naseerali CP, Hari PR, Sreenivasan K. The release kinetics of drug eluting stents containing sirolimus as coated drug: role of release media. J Chromatogr B Anal Technol Biomed Life Sci. 2010;878:709-12.
24. Okner R, Oron M, Tal N, Nyska A, Kumar N, Mandler D, et al. Electrocoating of stainless steel coronary stents for extended release of paclitaxel. J Biomed Mater Res A. 2009;88:427-36.
25. Uttayarat P, Chen M, Li M, Allen FD, Composto RJ, Lelkes PI. Microtopography and flow modulate the direction of endothelial cell migration. Am J Physiol Heart Circ Physiol. 2008;294:H1027-1035. (Pubitemid 351253317)
26. Mack MJ, Banning AP, Serruys PW, Morice MC, Taeymans Y, Van Nooten G, et al. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. Ann Thorac Surg. 2011;92:2140-6.
27. Barner HB. Status of percutaneous coronary intervention and coronary artery bypass. Eur J Cardio-Thorac. 2006;30:419-24. (Pubitemid 44192608)
28. Mo XM, Xu CY, Kotaki M, Ramakrishna S. Electrospun P(LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials. 2004;25:1883-90. (Pubitemid 38102263)
29. Zong X, Kim K, Fang D, Ran S, Hsiao B, Chu B. Structure and process relationship of electrospun bioabsorbable nanofiber membranes. Polymer. 2002;43:4403-12. (Pubitemid 34619697)
30. He SW, Li SS, Hu ZM, Yu JR, Chen L, Zhu J. Effects of three parameters on the diameter of electrospun poly(ethylene oxide) nanofibers. J Nanosci Nanotechnol. 2011;11:1052-9.
31. Han J, Chen TX, Branford-White CJ, Zhu LM. Electrospun shikonin-loaded PCL/PTMC composite fiber mats with potential biomedical applications. Int J Pharm. 2009;382:215-21.
32. Desai K, Kit K, Li J, Zivanovic S. Morphological and surface properties of electrospun chitosan nanofibers. Biomacromolecules. 2008;9:1000-6. (Pubitemid 351560494)
33. Gandhi PJ, Murthy ZVP. Solubility and crystal size of sirolimus in different organic solvents. J Chem Eng Data. 2010;55:5050-4.
34. Tan EP, Ng SY, Lim CT. Tensile testing of a single ultrafine polymeric fiber. Biomaterials. 2005;26:1453-6. (Pubitemid 39441377)
35. Ferron GM, Jusko WJ. Species differences in sirolimus stability in humans, rabbits, and rats. Drug Metab Dispos. 1998;26:83-4. (Pubitemid 28071330)
36. Simamora P, Alvarez JM, Yalkowsky SH. Solubilization of rapamycin. Int J Pharm. 2001;213:25-9. (Pubitemid 32119459)
37. Verreck G, Chun I, Rosenblatt J, Peeters J, Dijck AV, Mensch J, et al. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. J Control Release. 2003;92:349-60. (Pubitemid 38366156)
38. Yang Y, Li X, Cui W, Zhou S, Tan R, Wang C. Structural stability and release profiles of proteins from core-shell poly (DL-lactide) ultrafine fibers prepared by emulsion electrospinning. J Biomed Mater Res A. 2008;86:374-85. (Pubitemid 351969635)
39. Huatan H, Collett JH, Attwood D, Booth C. Preparation and characterization of poly(epsilon-caprolactone) polymer blends for the delivery of proteins. Biomaterials. 1995;16:1297-303.
40. Innocente F, Mandracchia D, Pektok E, Nottelet B, Tille JC, de Valence S, et al. Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step toward reduction of neointima formation? Circulation. 2009;120(11 Suppl):S37-45.